IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Caxton Corp

Q2 2013 Holdings

Filed 2013-08-14 | 2 holdings | $118.2K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Synta Pharmaceuticals CorpCOM87162T206$117.9K23,631,84999.8%
Hallmark Finl Svcs Inc ECCOM NEW40624Q203$25527,9000.2%